BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 4605566)

  • 1. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
    Carlson LA; Olsson AG; Orö L; Rössner S
    Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
    [No Abstract]   [Full Text] [Related]  

  • 2. An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate.
    Evans RJ; Howard AN; Hyams DE
    Angiology; 1973 Jan; 24(1):22-8. PubMed ID: 4694031
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
    Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):76-81. PubMed ID: 176639
    [No Abstract]   [Full Text] [Related]  

  • 5. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia.
    Howard AN; Hyams DE
    Br Med J; 1971 Jul; 3(5765):25-7. PubMed ID: 4933388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E; Aranda JL; Nogués X; del Palacio A; Rubiés-Prat J
    Med Clin (Barc); 1996 May; 106(20):776-9. PubMed ID: 8801396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM
    Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
    Glueck CJ; Tsang RC; Fallat RW; Mellies M
    Pediatrics; 1977 Mar; 59(3):433-41. PubMed ID: 840563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of lipid lowering drugs alone and in combination.
    Hansen PF
    Postgrad Med J; 1975; 51(8):63-5. PubMed ID: 768949
    [No Abstract]   [Full Text] [Related]  

  • 11. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
    Stein EA; Heimann KW
    S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholestyramine for elevated serum cholesterol.
    Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
    Lehtonen A; Viikari J
    Acta Med Scand; 1977; 202(3):179-81. PubMed ID: 333869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of cholestyramine as a hypocholesterolemic agent and its tolerance in a Mexican population].
    Lerman Garber I; Cardoso Saldaña G; Zamora González J; Ahumada Ayala M; García Rubí E; Posadas Romero C
    Arch Inst Cardiol Mex; 1991; 61(1):47-51. PubMed ID: 2048910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resins in the treatment of hypercholesterolemia].
    Jacotot B
    Med Chir Dig; 1978; 7(8):697-8. PubMed ID: 745469
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA; Grundy SM
    Arch Intern Med; 1995 Feb; 155(4):393-9. PubMed ID: 7848022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin.
    Faergeman O
    Acta Med Scand; 1973; 194(3):165-7. PubMed ID: 4746523
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
    Orö L; Olsson AG; Rössner S; Carlson LA
    Postgrad Med J; 1975; 51(8):suppl 76-81. PubMed ID: 215986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined drug therapy for familial hypercholesterolemia.
    Packard CJ; Stewart JM; Morgan HG; Lorimer AR; Shepherd J
    Artery; 1980; 7(4):281-9. PubMed ID: 7213018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.